Despite the recent evidence that TRAPPC4 deficiency is associated with a neurodevelopmental disorder, disease modelling advancements to further elucidate the neurological phenotype have not yet been attempted, with current functional testing being limited to patient fibroblasts and yeast models. The gene discussed is TRAPPC4; the disease is neurodevelopmental disorder.